Isabel Lozano Fernandez

Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain.

Instituto Biomar SL is a biotechnology company engaged in the discovery and development of marine microorganisms. It also provides clients with research, assay screening, compound analysis, and DNA and RNA sequencing services. The company was founded by Jose Luis Fernandez Puente in 1996 and is headquartered in León, Spain.

Instituto De Estudios Celulares Y Moleculares Icm SA engages in providing genetic investigation and analytical services. It offers gene testing, screening, and sequencing to ascertain an individual's pathological condition. It sells tests including TrainMee, genetic analysis of nutritional metabolism, test carriers of monogenic diseases, newborn screening for metabolopathies, and expanded panel examinations for diabetes, food intolerances, and breast and ovarian cancer. The firm also maintains a bioinformatics unit that stores genetic data that it examines. The company was founded on 1997 and is headquartered in Lugo, Spain.